Search research articles
Contact Us
Filters
Showing results (201-210 of 277) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
Matthew J Maurer, Hervé Ghesquières, Jean-Philippe Jais, et al.
Blood Cancer Journal
|
August 7, 2019
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Alyssa I Clay-Gilmour, Abdul R Rishi, Lynn R Goldin, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Leukemia
|
July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
Geffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Blood
|
April 19, 2018
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Emmanuel Bachy, Matthew J Maurer, Thomas M Habermann, et al.
Blood
|
December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
Susan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Cancer Research Communications
|
May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell Lymphoma
Mana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Paige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Mayo Clinic Proceedings
|
June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026
Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Blood Cancer Discovery
|
February 19, 2021
Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
Helene Kretzmer, Anat Biran, Noelia Purroy, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 277) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
Matthew J Maurer, Hervé Ghesquières, Jean-Philippe Jais, et al.
Blood Cancer Journal
|
August 7, 2019
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Alyssa I Clay-Gilmour, Abdul R Rishi, Lynn R Goldin, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Leukemia
|
July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
Geffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Blood
|
April 19, 2018
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Emmanuel Bachy, Matthew J Maurer, Thomas M Habermann, et al.
Blood
|
December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
Susan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Cancer Research Communications
|
May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell Lymphoma
Mana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Paige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Mayo Clinic Proceedings
|
June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026
Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Blood Cancer Discovery
|
February 19, 2021
Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
Helene Kretzmer, Anat Biran, Noelia Purroy, et al.
Page
of 28